Skip to content

Clinical trials

Completed Hematologic Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Status: Completed Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20132
20143
20151
20173
20182
20191
20204
20212
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
BioMarin Pharmaceutical2
Ellodi Pharmaceuticals, LP2
Genzyme, a Sanofi Company2
Sierra Oncology LLC - a GSK company2
Spark Therapeutics, Inc.2
Amgen1
European Society for Blood and Marrow Transplantation1
Pfizer1
Rallybio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases21
Blood Coagulation Disorders8
Blood Coagulation Disorders, Inherited7
Bone Marrow Diseases7
Hemorrhagic Disorders7
Coagulation Protein Disorders6
Genetic Diseases, Inborn6
Hemophilia A6
Genetic Diseases, X-Linked4
Leukemia4

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.